162. 類天疱瘡(後天性表皮水疱症を含む。)
[臨床試験数:70,薬物数:117(DrugBank:46),標的遺伝子数:30,標的パスウェイ数:128

Searched query = "Pemphigoid", "Epidermolysis bullosa acquisita"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-000480-41-IT
(EUCTR)
27/05/200810/06/2008Multicenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eyedrop treatment on patients with ocular cicatricial pemphigoid. - NDMulticenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eyedrop treatment on patients with ocular cicatricial pemphigoid. - ND Ocular cicatricial pemphigoid (OCP)
MedDRA version: 9.1;Level: LLT;Classification code 10010746;Term: Conjunctivitis chronic
Trade Name: RESTASIS
INN or Proposed INN: Cyclosporine
UNIVERSITA' CAMPUS BIOMEDICONULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy